a public good project by the
Synthesis
Company
of California

© 2026

Jun Yong Park | doi.page

0 works0 citations0 h-index

Jun Yong Park

Daewon Pharm (South Korea)(KR)Korea Research Institute of Bioscience and Biotechnology(KR)Jeonbuk National University(KR)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation

Most-Cited Works

→ Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ(2010)383 cited
→ Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)(2015)343 cited
→ Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial(2016)308 cited
→ Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients(2010)296 cited
→ Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis(2012)281 cited
→ A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis

(2010)

229 cited

→ Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage(2014)218 cited

→ Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma(2015)197 cited

→ Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance(2004)186 cited

→ A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease(2023)174 cited